A Massachusetts-based biotech company is stealing the mid-week spotlight so far during Wednesday’s session after the company announced Q3 2024 GAAP EPS of $(0.09), which...

To read the full story on AllPennyStocks.com, click here.

Mersana Therapeutics (NASDAQ:MRSN)
Historical Stock Chart
From Dec 2024 to Jan 2025 Click Here for more Mersana Therapeutics Charts.
Mersana Therapeutics (NASDAQ:MRSN)
Historical Stock Chart
From Jan 2024 to Jan 2025 Click Here for more Mersana Therapeutics Charts.